Compass Therapeutics, Inc. (CMPX)
NASDAQ: CMPX · Real-Time Price · USD
5.24
-0.15 (-2.78%)
Mar 20, 2026, 2:36 PM EDT - Market open
Compass Therapeutics Market Cap
Compass Therapeutics has a market cap or net worth of $943.66 million as of March 20, 2026. Its market cap has increased by 146.36% in one year.
Market Cap
943.66M
Enterprise Value
744.58M
1-Year Change
146.36%
Ranking
Category
Stock Price
$5.24
Market Cap Chart
Since April 5, 2021, Compass Therapeutics's market cap has increased from $435.34M to $943.66M, an increase of 116.76%. That is a compound annual growth rate of 16.89%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 19, 2026 | 970.67M | 1.63% |
| Dec 31, 2025 | 955.12M | 378.75% |
| Dec 31, 2024 | 199.50M | 0.34% |
| Dec 29, 2023 | 198.83M | -68.61% |
| Dec 30, 2022 | 633.47M | 105.02% |
| Dec 31, 2021 | 308.98M | -29.02% |
| Apr 5, 2021 | 435.34M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Bicara Therapeutics | 1.03B |
| ArriVent BioPharma | 1.01B |
| Geron | 992.84M |
| Xeris Biopharma Holdings | 962.17M |
| uniQure | 954.20M |
| Inhibrx Biosciences | 947.56M |
| Aktis Oncology | 944.35M |
| SELLAS Life Sciences Group | 933.83M |